<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Endocr Disord</journal-id><journal-id journal-id-type="iso-abbrev">BMC Endocr Disord</journal-id><journal-id journal-id-type="pmc-domain-id">27</journal-id><journal-id journal-id-type="pmc-domain">bmcendi</journal-id><journal-title-group><journal-title>BMC Endocrine Disorders</journal-title></journal-title-group><issn pub-type="epub">1472-6823</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12218965</article-id><article-id pub-id-type="pmcid-ver">PMC12218965.1</article-id><article-id pub-id-type="pmcaid">12218965</article-id><article-id pub-id-type="pmcaiid">12218965</article-id><article-id pub-id-type="pmid">40604906</article-id><article-id pub-id-type="doi">10.1186/s12902-025-01978-1</article-id><article-id pub-id-type="publisher-id">1978</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Association between neutrophil-to-high-density lipoprotein-cholesterol ratio and prevalence and mortality of diabetes: a cross-sectional study</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Tao</surname><given-names initials="Y">Yueting</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="Y">Yidan</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Guo</surname><given-names initials="S">Siqi</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Dong</surname><given-names initials="C">Chengzhen</given-names></name><address><email>chengzhendongcd@163.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label>Department of Endocrinology and Metabolism, Chengdu Seventh People&#8217;s Hospital, Chengdu, China </aff><aff id="Aff2"><label>2</label>Department of Neurology, Chengdu Seventh People&#8217;s Hospital, Chengdu, China </aff><aff id="Aff3"><label>3</label>Department of Nephrology, Chengdu Seventh People&#8217;s Hospital, Chengdu, China </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>7</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>25</volume><issue-id pub-id-type="pmc-issue-id">478358</issue-id><elocation-id>163</elocation-id><history><date date-type="received"><day>17</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>5</day><month>6</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>07</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>02</day><month>07</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-07-04 04:25:38.427"><day>04</day><month>07</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12902_2025_Article_1978.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Inflammatory responses and lipid metabolism play critical roles in diabetes development. This study explored the association between the neutrophil-to-high-density lipoprotein cholesterol ratio (NHR) and diabetes prevalence and mortality.</p></sec><sec><title>Methods</title><p id="Par2">This cross-sectional study was conducted in the National Health and Nutrition Survey (NHANES) from 1999 to 2018. The correlation between NHR and the prevalence of diabetes was evaluated using logistic regression models. Additionally, the Cox proportional hazards model was applied to investigate whether NHR related to the risk of mortality from all causes and cardiovascular diseases. A series of sensitivity analyses and subgroup analyses were performed to test the robustness of the findings.</p></sec><sec><title>Results</title><p id="Par3">Among the 52,428 study participants, 8,114 (15.48%) had diabetes, with a mean neutrophil-to-high-density lipoprotein cholesterol ratio (NHR) of 3.49. In the full-adjusted model, each unit increase in NHR was related to a 17.0% higher risk of diabetes (odds ratio, 1.17 [95% CI 1.13&#8211;1.21], <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001). Results were similar when participants were categorized by NHR tertiles (odds ratio, 2.08 [95% CI 1.76&#8211;2.47], comparing extreme quartiles). The stratified analyses showed that the association between NHR and risk of diabetes was more obvious in female, White, former smokers and participants with age&#8201;&#8805;&#8201;50&#160;years. After a&#160;median (interquartile range) follow-up of 9.42 (5.08&#8211;14.33) years, higher NHR levels were positively associated with the risk of all-cause and cardiovascular disease mortality in diabetes patients. A series of sensitivity analyses confirmed the robustness of the findings.</p></sec><sec><title>Conclusion</title><p id="Par4">Elevated NHR is linked to higher diabetes prevalence and increased mortality risk in a U.S. population, independent of traditional risk factors. Regular monitoring of NHR may serve as an easy-to-measure tool for risk stratification for&#160;diabetes and its adverse outcomes.</p></sec><sec><title>Clinical trial number</title><p id="Par5">Not applicable.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at10.1186/s12902-025-01978-1.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Diabetes</kwd><kwd>Neutrophil-to-high-density lipoprotein cholesterol ratio</kwd><kwd>Mortality</kwd><kwd>Risk factors</kwd><kwd>Prevention</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par14">Diabetes mellitus is currently at an unimaginable level of prevalence, with an estimated 439 million adult diabetes patients by 2030, of which over 90% are type 2 diabetes mellitus [<xref ref-type="bibr" rid="CR1">1</xref>]. Diabetes-related medical costs are estimated to be approximately $327 billion annually, which imposes a significant financial impact on families and society [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Individuals with diabetes have an increased risk of macrovascular and microvascular complications, including cardiovascular disease (CVD), nephropathy, retinopathy and neuropathy, but complications often arise too late and lack reliable treatments at that time [<xref ref-type="bibr" rid="CR3">3</xref>]. Thus, early identification and timely management of risk factors are crucial to reduce the significant burden of mortality and disability associated with diabetes.
</p><p id="Par15">In addition to blood glucose changes, inflammatory response and abnormal lipid metabolism are critical in causing and developing diabetes [<xref ref-type="bibr" rid="CR4">4</xref>&#8211;<xref ref-type="bibr" rid="CR6">6</xref>]. As an important component of the innate immune system, neutrophils play a central role in fighting infections and have been shown to be correlated with disease severity [<xref ref-type="bibr" rid="CR7">7</xref>]. Recently, higher neutrophils were confirmed to be related to higher glycemia and elevated glycated hemoglobin (HbA1c) levels, and further to increase the risk of all-cause and cardiovascular mortality in patients with diabetes [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. In addition, researchers have pointed out that lipid traits, especially high-density lipoprotein cholesterol (HDL-C) levels, can be used to predict the occurrence and progression of diabetes. Increasing HDL-C levels were usually accompanied by effective blood glucose control in patients with diabetes [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Furthermore, previous studies indicated that activated neutrophils could not only have an impact on the composition and function of HDL-C [<xref ref-type="bibr" rid="CR12">12</xref>], but its function could also be regulated by HDL-C [<xref ref-type="bibr" rid="CR13">13</xref>]. In recent years, the neutrophil-to-high-density lipoprotein cholesterol ratio (NHR) has been proposed as a comprehensive indicator of inflammation and lipid metabolic status, providing insights into their combined effects on disease development. Its measurement is simple, affordable, and standardized, positioning NHR as a potential clinical tool [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Research suggests that NHR is superior to the monocyte to high-density lipoprotein cholesterol ratio (MHR) and the neutrophil to lymphocyte ratio in predicting certain diseases [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Moreover, NHR exhibited great predictive accuracy in hypertension, stroke and cardiovascular risk [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. As inflammation and lipid disorders are important key features of diabetes, it is of clinical relevance to explore the role of NHR in diabetes and predicting its adverse outcomes.</p><p id="Par16">To address this knowledge gap, we aimed to assess the association of NHR with diabetes and with all-cause and cardiovascular mortality in diabetic participants, using data from the National Health and Nutrition Examination Survey (NHANES).</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Study population</title><p id="Par17">The NHANES, organized by the National Center for Health Statistics (NCHS), is a nationwide program designed to collect comprehensive health and nutrition data through a multistage, stratified probability sampling method [<xref ref-type="bibr" rid="CR20">20</xref>]. This ongoing surveillance program offers insights into the health status of adults and children in the United States. Ethical approval for the study was granted by the NCHS Ethics Review Committee, and all participants provided written informed consent. Data from ten NHANES cycles (1999&#8211;2018) were analyzed. Participants under 18 years, those lacking data for NHR calculation, or missing mortality information were excluded, resulting in a final sample of 52,428 individuals for examining the association between NHR and diabetes risk. Additionally, a subset of 8,114 participants with pre-existing diabetes were analyzed to explore the relationship between NHR and mortality outcomes, including all-cause and CVD mortality (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Flowchart for selecting the participants for analysis</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="12902_2025_1978_Fig1_HTML.jpg"/></fig></p></sec><sec id="Sec4"><title>Assessment of NHR, diabetes and mortality</title><p id="Par18">Blood samples were collected at NHANES mobile examination centers following standardized protocols. Neutrophil counts were measured using a Beckman Coulter DxH 800 analyzer, which utilizes multiparameter flow cytometry technology. HDL-C levels were enzymatically quantified using Roche analyzers. All measurements followed standardized NHANES laboratory protocols, ensuring methodological consistency and reproducibility. NHR was calculated as the ratio of absolute neutrophil count (1000 cells/&#956;L) to HDL-C concentration (mg/dL), as per established methods [<xref ref-type="bibr" rid="CR17">17</xref>]. Diabetes diagnosis was based on the 2021 American Diabetes Association (ADA) diagnostic criteria [<xref ref-type="bibr" rid="CR21">21</xref>], defined by meeting any of the following: (1) self-reported physician-diagnosed diabetes (ascertained through affirmative response to the question:"Has a doctor ever told you that you have diabetes?"); (2) current use of diabetes medications; (3) fasting plasma glucose &#8805;&#8201;7.0 mmol/L (126 mg/dL); (4) HbA1c &#8805;&#8201;6.5% (48 mmol/mol); or (5) 2-h plasma glucose &#8805;&#8201;11.1 mmol/L (200 mg/dL) during an oral glucose tolerance test.</p></sec><sec id="Sec5"><title>Mortality ascertainment</title><p id="Par19">Mortality data, encompassing all-cause and CVD-specific deaths for individuals with diabetes, were linked to the National Death Index and verified through death certificates up to December 31, 2019. CVD-related deaths were classified using ICD-10 codes for heart and cerebrovascular diseases (I00&#8211;I09, I11, I13, I20&#8211;I51, I60&#8211;I69) [<xref ref-type="bibr" rid="CR22">22</xref>]. The follow-up period spanned from the baseline examination date to the date of death or December 31, 2019, whichever occurred first.</p></sec><sec id="Sec6"><title>Covariates</title><p id="Par20">The study included sociodemographic and health-related covariates such as sex, age, race, marital status, poverty-to-income ratio (PIR), education level, alcohol consumption, smoking, physical activity, body mass index (BMI), and comorbid conditions. Race categories were non-Hispanic White, Mexican American, non-Hispanic Black, and others. BMI was categorized based on established clinical cutoff values (&lt; 25 kg/m<sup>2</sup>, 25&#8211;30 kg/m<sup>2</sup>, &#8805;&#8201;30 kg/m<sup>2</sup>). Educational attainment was grouped as less than high school versus high school graduate or higher. PIR &#8804;&#8201;1.3 indicated poverty [<xref ref-type="bibr" rid="CR23">23</xref>]. Marital status was categorized as married/cohabiting or unmarried. Smoking history was classified into never, former, or current smokers, while alcohol consumption was considered positive if participants reported drinking more than 12 alcoholic beverages in the past year. Physical activity levels were categorized as inactive, moderate, vigorous, or both moderate and vigorous. Insulin resistance was assessed using the homeostasis model assessment of insulin resistance (HOMA-IR), calculated as: HOMA-IR =&#8201;(fasting blood glucose [mmol/L] &#215;&#8201;fasting serum insulin [&#956;U/mL])/22.5 [<xref ref-type="bibr" rid="CR24">24</xref>]. A HOMA-IR value &gt;&#8201;2.6 was considered indicative of insulin resistance, as previously reported [<xref ref-type="bibr" rid="CR25">25</xref>]. Statin and anti-diabetic medication use was determined based on self-reported prescription medications. Hypertension was defined by self-reported diagnosis, use of antihypertensive drugs, or blood pressure measurements (systolic &#8805;&#8201;140 mmHg or diastolic &#8805;&#8201;90 mmHg). Stroke and heart failure history were based on self-reported physician diagnoses.</p></sec><sec id="Sec7"><title>Statistical analysis</title><p id="Par21">Analyses employed sampling weights to account for the complex NHANES survey design and generate representative national estimates [<xref ref-type="bibr" rid="CR26">26</xref>]. Given the absence of established clinical cut-offs for the NHR, participants were stratified into tertiles (tertile 1 (&lt; 2.47), tertile 2 (2.47&#8211;3.86), and tertile 3 (&#8805; 3.86)) for analysis. Baseline characteristics were summarized across NHR tertiles, presenting continuous variables as weighted means &#177;&#8201;standard errors and categorical variables as weighted proportions (%). Group differences were analyzed using Chi-square tests or analysis of variance. Missing values in categorical covariates were addressed using the missing indicator method, with the specific proportions of missing data presented in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>.
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Characteristics of the study population according to the neutrophil-to-high-density lipoprotein-cholesterol (NHR) categories</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Variables</th><th align="left" colspan="1" rowspan="1">Total</th><th align="left" colspan="1" rowspan="1">Tertile 1 (&lt; 2.47)</th><th align="left" colspan="1" rowspan="1">Tertile 2 (2.47&#8211;3.86)</th><th align="left" colspan="1" rowspan="1">Tertile 3 (&#8805; 3.86)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th></tr><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">N =&#8201;52,428</th><th align="left" colspan="1" rowspan="1">N =&#8201;17,477</th><th align="left" colspan="1" rowspan="1">N =&#8201;17,482</th><th align="left" colspan="1" rowspan="1">N =&#8201;17,469</th><th align="left" colspan="1" rowspan="1"/></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">NHR</td><td align="left" colspan="1" rowspan="1">3.49 &#177;&#8201;0.02</td><td align="left" colspan="1" rowspan="1">1.81 &#177;&#8201;0.01</td><td align="left" colspan="1" rowspan="1">3.11 &#177;&#8201;0.01</td><td align="left" colspan="1" rowspan="1">5.51 &#177;&#8201;0.02</td><td align="left" colspan="1" rowspan="1">&#8201;&lt; 0.001</td></tr><tr><td align="left" colspan="5" rowspan="1">Gender</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Male</td><td align="left" colspan="1" rowspan="1">25,413 (48.47%)</td><td align="left" colspan="1" rowspan="1">7129 (40.79%)</td><td align="left" colspan="1" rowspan="1">8506 (48.66%)</td><td align="left" colspan="1" rowspan="1">9778 (55.97%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Female</td><td align="left" colspan="1" rowspan="1">27,015 (51.53%)</td><td align="left" colspan="1" rowspan="1">10,348 (59.21%)</td><td align="left" colspan="1" rowspan="1">8976 (51.34%)</td><td align="left" colspan="1" rowspan="1">7691 (44.03%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Age, years</td><td align="left" colspan="1" rowspan="1">47.51 &#177;&#8201;19.23</td><td align="left" colspan="1" rowspan="1">48.55 &#177;&#8201;19.19</td><td align="left" colspan="1" rowspan="1">47.81 &#177;&#8201;19.36</td><td align="left" colspan="1" rowspan="1">46.17 &#177;&#8201;19.06</td><td align="left" colspan="1" rowspan="1">&#8201;&lt; 0.001</td></tr><tr><td align="left" colspan="5" rowspan="1">Race</td><td align="left" colspan="1" rowspan="1">&#8201;&lt; 0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Non-Hispanic White</td><td align="left" colspan="1" rowspan="1">22,784 (43.46%)</td><td align="left" colspan="1" rowspan="1">6625 (37.91%)</td><td align="left" colspan="1" rowspan="1">7662 (43.83%)</td><td align="left" colspan="1" rowspan="1">8497 (48.64%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Non-Hispanic Black</td><td align="left" colspan="1" rowspan="1">10,828 (20.65%)</td><td align="left" colspan="1" rowspan="1">5676 (32.48%)</td><td align="left" colspan="1" rowspan="1">3083 (17.64%)</td><td align="left" colspan="1" rowspan="1">2069 (11.84%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Mexican American</td><td align="left" colspan="1" rowspan="1">9766 (18.63%)</td><td align="left" colspan="1" rowspan="1">2229 (12.75%)</td><td align="left" colspan="1" rowspan="1">3614 (20.67%)</td><td align="left" colspan="1" rowspan="1">3923 (22.46%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Other</td><td align="left" colspan="1" rowspan="1">9050 (17.26%)</td><td align="left" colspan="1" rowspan="1">2947 (16.86%)</td><td align="left" colspan="1" rowspan="1">3123 (17.86%)</td><td align="left" colspan="1" rowspan="1">2980 (17.06%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Marital status</td><td align="left" colspan="1" rowspan="1">&#8201;&lt; 0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Yes</td><td align="left" colspan="1" rowspan="1">29,495 (56.26%)</td><td align="left" colspan="1" rowspan="1">9298 (53.20%)</td><td align="left" colspan="1" rowspan="1">10,007 (57.24%)</td><td align="left" colspan="1" rowspan="1">10,190 (58.33%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;No</td><td align="left" colspan="1" rowspan="1">20,876 (39.82%)</td><td align="left" colspan="1" rowspan="1">7438 (42.56%)</td><td align="left" colspan="1" rowspan="1">6788 (38.83%)</td><td align="left" colspan="1" rowspan="1">6650 (38.07%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Missing</td><td align="left" colspan="1" rowspan="1">2057 (3.92%)</td><td align="left" colspan="1" rowspan="1">741 (4.24%)</td><td align="left" colspan="1" rowspan="1">687 (3.93%)</td><td align="left" colspan="1" rowspan="1">629 (3.60%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Education level</td><td align="left" colspan="1" rowspan="1">&#8201;&lt; 0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Below high school</td><td align="left" colspan="1" rowspan="1">13,164 (25.11%)</td><td align="left" colspan="1" rowspan="1">3783 (21.65%)</td><td align="left" colspan="1" rowspan="1">4440 (25.40%)</td><td align="left" colspan="1" rowspan="1">4941 (28.28%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;High School or above</td><td align="left" colspan="1" rowspan="1">35,585 (67.87%)</td><td align="left" colspan="1" rowspan="1">12,441 (71.18%)</td><td align="left" colspan="1" rowspan="1">11,824 (67.64%)</td><td align="left" colspan="1" rowspan="1">11,320 (64.80%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Missing</td><td align="left" colspan="1" rowspan="1">3679 (7.02%)</td><td align="left" colspan="1" rowspan="1">1253 (7.17%)</td><td align="left" colspan="1" rowspan="1">1218 (6.97%)</td><td align="left" colspan="1" rowspan="1">1208 (6.92%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">PIR categories</td><td align="left" colspan="1" rowspan="1">&#8201;&lt; 0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Poor</td><td align="left" colspan="1" rowspan="1">10,357 (19.75%)</td><td align="left" colspan="1" rowspan="1">3053 (17.47%)</td><td align="left" colspan="1" rowspan="1">3372 (19.29%)</td><td align="left" colspan="1" rowspan="1">3932 (22.51%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Not poor</td><td align="left" colspan="1" rowspan="1">37,513 (71.55%)</td><td align="left" colspan="1" rowspan="1">12,848 (73.51%)</td><td align="left" colspan="1" rowspan="1">12,602 (72.09%)</td><td align="left" colspan="1" rowspan="1">12,063 (69.05%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Missing</td><td align="left" colspan="1" rowspan="1">4558 (8.69%)</td><td align="left" colspan="1" rowspan="1">1576 (9.02%)</td><td align="left" colspan="1" rowspan="1">1508 (8.63%)</td><td align="left" colspan="1" rowspan="1">1474 (8.44%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">BMI categories</td><td align="left" colspan="1" rowspan="1">&#8195;&#8195;&lt; 0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;&lt; 25 kg/m<sup>2</sup></td><td align="left" colspan="1" rowspan="1">16,178 (30.86%)</td><td align="left" colspan="1" rowspan="1">7606 (43.52%)</td><td align="left" colspan="1" rowspan="1">5109 (29.22%)</td><td align="left" colspan="1" rowspan="1">3463 (19.82%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;25&#8211;30 kg/m<sup>2</sup></td><td align="left" colspan="1" rowspan="1">17,101 (32.62%)</td><td align="left" colspan="1" rowspan="1">5585 (31.96%)</td><td align="left" colspan="1" rowspan="1">5999 (34.32%)</td><td align="left" colspan="1" rowspan="1">5517 (31.58%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;&#8805; 30 kg/m<sup>2</sup></td><td align="left" colspan="1" rowspan="1">18,249 (34.81%)</td><td align="left" colspan="1" rowspan="1">4034 (23.08%)</td><td align="left" colspan="1" rowspan="1">6075 (34.75%)</td><td align="left" colspan="1" rowspan="1">8140 (46.60%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Missing</td><td align="left" colspan="1" rowspan="1">900 (1.72%)</td><td align="left" colspan="1" rowspan="1">252 (1.44%)</td><td align="left" colspan="1" rowspan="1">299 (1.71%)</td><td align="left" colspan="1" rowspan="1">349 (2.00%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Smoking status</td><td align="left" colspan="1" rowspan="1">&#8195;&lt; 0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Current</td><td align="left" colspan="1" rowspan="1">10,224 (19.50%)</td><td align="left" colspan="1" rowspan="1">2446 (14.00%)</td><td align="left" colspan="1" rowspan="1">3029 (17.33%)</td><td align="left" colspan="1" rowspan="1">4749 (27.19%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Former</td><td align="left" colspan="1" rowspan="1">12,156 (23.19%)</td><td align="left" colspan="1" rowspan="1">3932 (22.50%)</td><td align="left" colspan="1" rowspan="1">4137 (23.66%)</td><td align="left" colspan="1" rowspan="1">4087 (23.40%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Never</td><td align="left" colspan="1" rowspan="1">27,157 (51.80%)</td><td align="left" colspan="1" rowspan="1">10,125 (57.93%)</td><td align="left" colspan="1" rowspan="1">9361 (53.55%)</td><td align="left" colspan="1" rowspan="1">7671 (43.91%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Missing</td><td align="left" colspan="1" rowspan="1">2891 (5.51%)</td><td align="left" colspan="1" rowspan="1">974 (5.57%)</td><td align="left" colspan="1" rowspan="1">955 (5.46%)</td><td align="left" colspan="1" rowspan="1">962 (5.51%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Drinking status</td><td align="left" colspan="1" rowspan="1">0.151</td></tr><tr><td align="left" colspan="1" rowspan="1"> Yes</td><td align="left" colspan="1" rowspan="1">30,784 (58.72%)</td><td align="left" colspan="1" rowspan="1">10,191 (58.31%)</td><td align="left" colspan="1" rowspan="1">10,206 (58.38%)</td><td align="left" colspan="1" rowspan="1">10,387 (59.46%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;No</td><td align="left" colspan="1" rowspan="1">14,678 (28.00%)</td><td align="left" colspan="1" rowspan="1">4938 (28.25%)</td><td align="left" colspan="1" rowspan="1">4960 (28.37%)</td><td align="left" colspan="1" rowspan="1">4780 (27.36%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Missing</td><td align="left" colspan="1" rowspan="1">6966 (13.29%)</td><td align="left" colspan="1" rowspan="1">2348 (13.43%)</td><td align="left" colspan="1" rowspan="1">2316 (13.25%)</td><td align="left" colspan="1" rowspan="1">2302 (13.18%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Physical activity</td><td align="left" colspan="1" rowspan="1">&#8195;&lt; 0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Inactive</td><td align="left" colspan="1" rowspan="1">19,394 (36.99%)</td><td align="left" colspan="1" rowspan="1">6862 (39.26%)</td><td align="left" colspan="1" rowspan="1">6331 (36.21%)</td><td align="left" colspan="1" rowspan="1">6201 (35.50%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Moderate</td><td align="left" colspan="1" rowspan="1">12,363 (23.58%)</td><td align="left" colspan="1" rowspan="1">4113 (23.53%)</td><td align="left" colspan="1" rowspan="1">4181 (23.92%)</td><td align="left" colspan="1" rowspan="1">4069 (23.29%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Vigorous</td><td align="left" colspan="1" rowspan="1">3525 (6.72%)</td><td align="left" colspan="1" rowspan="1">1188 (6.80%)</td><td align="left" colspan="1" rowspan="1">1121 (6.41%)</td><td align="left" colspan="1" rowspan="1">1216 (6.96%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Both moderate and vigorous</td><td align="left" colspan="1" rowspan="1">8979 (17.13%)</td><td align="left" colspan="1" rowspan="1">3061 (17.51%)</td><td align="left" colspan="1" rowspan="1">2985 (17.07%)</td><td align="left" colspan="1" rowspan="1">2933 (16.79%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Missing</td><td align="left" colspan="1" rowspan="1">8167 (15.58%)</td><td align="left" colspan="1" rowspan="1">2253 (12.89%)</td><td align="left" colspan="1" rowspan="1">2864 (16.38%)</td><td align="left" colspan="1" rowspan="1">3050 (17.46%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Hypertension</td><td align="left" colspan="1" rowspan="1">&#8201;&lt; 0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Yes</td><td align="left" colspan="1" rowspan="1">20,691 (39.47%)</td><td align="left" colspan="1" rowspan="1">6501 (37.20%)</td><td align="left" colspan="1" rowspan="1">6890 (39.41%)</td><td align="left" colspan="1" rowspan="1">7300 (41.79%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;No</td><td align="left" colspan="1" rowspan="1">31,724 (60.51%)</td><td align="left" colspan="1" rowspan="1">10,973 (62.79%)</td><td align="left" colspan="1" rowspan="1">10,588 (60.57%)</td><td align="left" colspan="1" rowspan="1">10,163 (58.18%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Missing</td><td align="left" colspan="1" rowspan="1">13 (0.02%)</td><td align="left" colspan="1" rowspan="1">3 (0.02%)</td><td align="left" colspan="1" rowspan="1">4 (0.02%)</td><td align="left" colspan="1" rowspan="1">6 (0.03%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Stroke</td><td align="left" colspan="1" rowspan="1">&#8195;&lt; 0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Yes</td><td align="left" colspan="1" rowspan="1">1830 (3.49%)</td><td align="left" colspan="1" rowspan="1">490 (2.80%)</td><td align="left" colspan="1" rowspan="1">599 (3.43%)</td><td align="left" colspan="1" rowspan="1">741 (4.24%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;No</td><td align="left" colspan="1" rowspan="1">46,926 (89.51%)</td><td align="left" colspan="1" rowspan="1">15,743 (90.08%)</td><td align="left" colspan="1" rowspan="1">15,669 (89.63%)</td><td align="left" colspan="1" rowspan="1">15,514 (88.81%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Missing</td><td align="left" colspan="1" rowspan="1">3672 (7.00%)</td><td align="left" colspan="1" rowspan="1">1244 (7.12%)</td><td align="left" colspan="1" rowspan="1">1214 (6.94%)</td><td align="left" colspan="1" rowspan="1">1214 (6.95%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Heart failure</td><td align="left" colspan="1" rowspan="1">&#8201;&lt; 0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Yes</td><td align="left" colspan="1" rowspan="1">1588 (3.03%)</td><td align="left" colspan="1" rowspan="1">356 (2.04%)</td><td align="left" colspan="1" rowspan="1">480 (2.75%)</td><td align="left" colspan="1" rowspan="1">752 (4.30%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;No</td><td align="left" colspan="1" rowspan="1">47,081 (89.80%)</td><td align="left" colspan="1" rowspan="1">15,852 (90.70%)</td><td align="left" colspan="1" rowspan="1">15,751 (90.10%)</td><td align="left" colspan="1" rowspan="1">15,478 (88.60%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Missing</td><td align="left" colspan="1" rowspan="1">3759 (7.17%)</td><td align="left" colspan="1" rowspan="1">1269 (7.26%)</td><td align="left" colspan="1" rowspan="1">1251 (7.16%)</td><td align="left" colspan="1" rowspan="1">1239 (7.09%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Insulin resistance</td><td align="left" colspan="1" rowspan="1">&#8201;&lt; 0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Yes</td><td align="left" colspan="1" rowspan="1">10,550 (20.12%)</td><td align="left" colspan="1" rowspan="1">2700 (15.45%)</td><td align="left" colspan="1" rowspan="1">3792 (21.69%)</td><td align="left" colspan="1" rowspan="1">4058 (23.23%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;No</td><td align="left" colspan="1" rowspan="1">12,168 (23.21%)</td><td align="left" colspan="1" rowspan="1">6179 (35.36%)</td><td align="left" colspan="1" rowspan="1">3747 (21.43%)</td><td align="left" colspan="1" rowspan="1">2242 (12.83%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Missing</td><td align="left" colspan="1" rowspan="1">29,710 (56.67%)</td><td align="left" colspan="1" rowspan="1">8598 (49.20%)</td><td align="left" colspan="1" rowspan="1">9943 (56.88%)</td><td align="left" colspan="1" rowspan="1">11,169 (63.94%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Anti-diabetic drug use</td><td align="left" colspan="1" rowspan="1">&#8201;&lt; 0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Yes</td><td align="left" colspan="1" rowspan="1">5318 (10.14%)</td><td align="left" colspan="1" rowspan="1">1147 (6.56%)</td><td align="left" colspan="1" rowspan="1">1763 (10.08%)</td><td align="left" colspan="1" rowspan="1">2408 (13.78%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;No</td><td align="left" colspan="1" rowspan="1">47,110 (89.86%)</td><td align="left" colspan="1" rowspan="1">16,330 (93.44%)</td><td align="left" colspan="1" rowspan="1">15,719 (89.92%)</td><td align="left" colspan="1" rowspan="1">15,061 (86.22%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Statin use</td><td align="left" colspan="1" rowspan="1">&#8201;&lt; 0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Yes</td><td align="left" colspan="1" rowspan="1">7983 (15.23%)</td><td align="left" colspan="1" rowspan="1">2295 (13.13%)</td><td align="left" colspan="1" rowspan="1">2790 (15.96%)</td><td align="left" colspan="1" rowspan="1">2898 (16.59%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;No</td><td align="left" colspan="1" rowspan="1">44,445 (84.77%)</td><td align="left" colspan="1" rowspan="1">15,182 (86.87%)</td><td align="left" colspan="1" rowspan="1">14,692 (84.04%)</td><td align="left" colspan="1" rowspan="1">14,571 (83.41%)</td><td align="left" colspan="1" rowspan="1"/></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">BMI</italic> Body mass index, <italic toggle="yes">PIR</italic> Poverty-to-income ratio</p></table-wrap-foot></table-wrap></p><p id="Par22">Weighted logistic regression models were employed to evaluate the association between NHR and diabetes risk. Two hierarchical models were constructed: 1) a partially adjusted model controlling for age and sex, and 2) a fully adjusted model that additionally incorporated established diabetes determinants and potential confounders identified from prior literature, including race/ethnicity, marital status, educational attainment, BMI, PIR, smoking status, alcohol consumption, physical activity level, HOMA-IR, use of glucose-lowering medications, statin use, and history of hypertension, stroke, and heart failure [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Trend analysis treated NHR tertile medians as continuous variables. For diabetes-related mortality, weighted Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals. Restricted cubic splines were performed to evaluate dose&#8211;response relationships between NHR and diabetes or mortality outcomes, adjusting for covariates.</p><p id="Par23">Stratified analyses were conducted to assess potential effect modification by variables such as age, sex, race, education level, PIR categories, smoking, alcohol consumption, statin use, and physical activity. Interaction significance was evaluated using likelihood ratio tests, comparing models with and without interaction terms. To ensure the robustness of our findings, we performed several sensitivity analyses. First, we restricted analyses to participants with fasting glucose measurements. Second, we conducted complete-case analyses by excluding individuals with missing covariate data. Third, to address potential selection bias from complete-case exclusion, we additionally implemented multiple imputation approaches to handle missing data. Fourth, to address potential reverse causation, we repeated mortality analyses after excluding deaths that occurred within the first two years of follow-up. All statistical analyses were carried out using R software (version 4.2.3, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.r-project.org/">http://www.r-project.org/</ext-link>), with statistical significance defined as a two-sided <italic toggle="yes">P</italic> value &lt;&#8201;0.05.</p></sec></sec><sec id="Sec8"><title>Results</title><sec id="Sec9"><title>Baseline characteristics according to tertiles of NHR</title><p id="Par24">The average age of participants was 47.51 &#177;&#8201;19.23 years, with 25,413 (48.47%) being men, 10,224 (19.50%) current smokers, and 20,691 (39.47%) diagnosed with hypertension (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). The population was divided into three groups based on baseline NHR tertiles (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). Participants with higher NHR values were generally younger, more likely to be male, white, current smokers, and drinkers, and had higher rates of hypertension, stroke, and heart failure. They also demonstrated lower education levels, and PIR, but higher physical activity levels (all <italic toggle="yes">P</italic>&#8201;&lt; 0.001).</p></sec><sec id="Sec10"><title>Association between NHR and risk of diabetes</title><p id="Par25">Participants with diabetes were more likely to be older, less educated, have a higher PIR and BMI, engage in less physical activity, and exhibit more severe insulin resistance. Notably, they had significantly higher NHR levels (4.02 &#177;&#8201;2.04 vs. 3.38 &#177;&#8201;1.98, <italic toggle="yes">P</italic>&#8201;&lt; 0.001) (Supplemental Table <xref rid="MOESM1" ref-type="media">1</xref>). Table <xref rid="Tab2" ref-type="table">2</xref> summarizes the associations between NHR and diabetes across three models. In the multivariable analysis treating NHR as a continuous variable, a 1-unit increase in NHR was associated with a 17% higher likelihood of diabetes after adjusting for potential confounders (OR, 1.17 [95% CI, 1.13&#8211;1.21]). Similar results were observed when participants were grouped by NHR tertiles, with the highest diabetes risk found in the top tertile (all <italic toggle="yes">P</italic>&#8201;&lt; 0.001, Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). In the fully adjusted model, the ORs (95% CIs) for diabetes were 1.30 (1.12&#8211;1.51) and 2.08 (1.76&#8211;2.47) for the second and third tertiles, respectively, compared to the first tertile (model 3, Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). Restricted cubic splines indicated a non-linear relationship between NHR and risk of diabetes (non-linear <italic toggle="yes">P</italic>&#8201;&lt; 0.001, Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>A).
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>The association between neutrophil-to-high-density lipoprotein-cholesterol (NHR) and type 2 diabetes (<italic toggle="yes">N</italic>&#8201;= 52,428)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="3" rowspan="1">OR (95% CI), <italic toggle="yes">P</italic> value</th></tr><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Cases/participants (%)</th><th align="left" colspan="1" rowspan="1">Crude model (Model 1)</th><th align="left" colspan="1" rowspan="1">Partially adjusted model (Model 2)</th><th align="left" colspan="1" rowspan="1">Fully adjusted model (Model 3)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">NHR</td><td align="left" colspan="1" rowspan="1">8114/52428 (15.48%)</td><td align="left" colspan="1" rowspan="1">1.22 (1.20&#8211;1.24), &lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">1.28 (1.26&#8211;1.31), &lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">1.17 (1.13&#8211;1.21), &lt;&#8201;0.001</td></tr><tr><td align="left" colspan="5" rowspan="1">NHR tertiles</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Tertile 1 (&lt; 2.47)</td><td align="left" colspan="1" rowspan="1">1796/17477(10.28%)</td><td align="left" colspan="1" rowspan="1">Reference</td><td align="left" colspan="1" rowspan="1">Reference</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Tertile 2 (2.47&#8211;3.86)</td><td align="left" colspan="1" rowspan="1">2690/17482(15.39%)</td><td align="left" colspan="1" rowspan="1">1.72 (1.59&#8211;1.87), &lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">1.86 (1.70&#8211;2.03), &lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">1.30 (1.12&#8211;1.51), &lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Tertile 3 (&#8805; 3.86)</td><td align="left" colspan="1" rowspan="1">3628/17469 (20.77%)</td><td align="left" colspan="1" rowspan="1">2.90 (2.68&#8211;3.13), &lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">3.62 (3.32&#8211;3.94), &lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">2.08 (1.76&#8211;2.47), &lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for trend</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt; 0.001</td><td align="left" colspan="1" rowspan="1">&#8201;&lt; 0.001</td><td align="left" colspan="1" rowspan="1">&#8201;&lt; 0.001</td></tr></tbody></table><table-wrap-foot><p>Model 1: unadjusted model. Model 2: adjusted for sex and age. Model 3: model 2 plus race, marital status, education level, body mass index categories, poverty-to-income ratio categories, smoking status, drinking status, anti-diabetic drug use, statin use, insulin resistance, physical activity, hypertension, stroke, and heart failure. <italic toggle="yes">CI</italic> confidence interval, <italic toggle="yes">OR</italic> Odds ratio</p></table-wrap-foot></table-wrap><fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Restricted cubic spline curves demonstrate associations of baseline neutrophil-to-high-density lipoprotein-cholesterol ratio with: (<bold>A</bold>) diabetes incidence, (<bold>B</bold>) all-cause mortality, and (<bold>C</bold>) cardiovascular disease related mortality in diabetic participants</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="12902_2025_1978_Fig2_HTML.jpg"/></fig></p></sec><sec id="Sec11"><title>Association of NHR with all-cause and CVD mortality in diabetes</title><p id="Par26">During a&#160;median (interquartile range) follow-up of 9.42 (5.08&#8211;14.33) years, 2288 incident all-cause deaths (28.2%) and 785 (9.67%) CVD deaths were observed. Table <xref rid="Tab3" ref-type="table">3</xref> shows that elevated NHR was significantly associated with higher risks of all-cause mortality (HR, 1.07; 95% CI, 1.04&#8211;1.11) and cardiovascular mortality (HR, 1.08; 95% CI, 1.04&#8211;1.13) in individuals with diabetes after full adjustment. When stratified by sex, we observed that the elevated NHR had greater impact on the risk of all-cause and CVD mortality in women with diabetes (Table&#160;<xref rid="Tab3" ref-type="table">3</xref>). The restricted cubic splines further showed that NHR was nearly linearly associated with risk of all-cause or CVD mortality (both <italic toggle="yes">P</italic>&#8201;for overall&#160;&lt; 0.001, Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>B-C).
<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>The association between NHR and all-cause and CVD mortality among participants with type 2 diabetes</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="3" rowspan="1"><bold>All-cause mortality,</bold> HR (95% CI), <italic toggle="yes">P</italic> value</th><th align="left" colspan="3" rowspan="1"><bold>CVD mortality,</bold> HR (95% CI), <italic toggle="yes">P</italic> value</th></tr><tr><th align="left" colspan="1" rowspan="1"><bold>Groups</bold></th><th align="left" colspan="1" rowspan="1"><bold>All</bold></th><th align="left" colspan="1" rowspan="1"><bold>Male</bold></th><th align="left" colspan="1" rowspan="1"><bold>Female</bold></th><th align="left" colspan="1" rowspan="1"><bold>All</bold></th><th align="left" colspan="1" rowspan="1"><bold>Male</bold></th><th align="left" colspan="1" rowspan="1"><bold>Female</bold></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Cases/participants (%)</td><td align="left" colspan="1" rowspan="1">2288/8114 (28.2%)</td><td align="left" colspan="1" rowspan="1">1308/4228 (30.94%)</td><td align="left" colspan="1" rowspan="1">980/3886 (25.22%)</td><td align="left" colspan="1" rowspan="1">785/8114 (9.67%)</td><td align="left" colspan="1" rowspan="1">450/4228 (10.64%)</td><td align="left" colspan="1" rowspan="1">335/3886 (8.62%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Model 1</td><td align="left" colspan="1" rowspan="1">1.03 (1.00&#8211;1.06), 0.039</td><td align="left" colspan="1" rowspan="1">1.02 (0.98&#8211;1.06), 0.315</td><td align="left" colspan="1" rowspan="1">1.04 (1.00&#8211;1.08), 0.066</td><td align="left" colspan="1" rowspan="1">1.03 (0.99&#8211;1.07), 0.193</td><td align="left" colspan="1" rowspan="1">1.03 (0.97&#8211;1.08), 0.335</td><td align="left" colspan="1" rowspan="1">1.02 (0.96&#8211;1.09), 0.504</td></tr><tr><td align="left" colspan="1" rowspan="1">Model 2</td><td align="left" colspan="1" rowspan="1">1.08 (1.05&#8211;1.12), &lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">1.05 (1.02&#8211;1.10), 0.006</td><td align="left" colspan="1" rowspan="1">1.12 (1.07&#8211;1.18), &lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">1.09 (1.04&#8211;1.13), &lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">1.07 (1.01&#8211;1.13), 0.021</td><td align="left" colspan="1" rowspan="1">1.11 (1.05&#8211;1.18), &lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Model 3</td><td align="left" colspan="1" rowspan="1">1.07 (1.04&#8211;1.11), &lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">1.02 (0.98&#8211;1.07), 0.276</td><td align="left" colspan="1" rowspan="1">1.10 (1.05&#8211;1.16), &lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">1.08 (1.04&#8211;1.13), &lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">1.02 (0.96&#8211;1.09), 0.484</td><td align="left" colspan="1" rowspan="1">1.10 (1.03&#8211;1.17), 0.004</td></tr></tbody></table><table-wrap-foot><p>Model 1: unadjusted model. Model 2: adjusted for age and sex. Model 3: model 2 plus race, marital status, education level, body mass index categories, poverty income ratio categories, smoking status, drinking status, anti-diabetic drug use, statin use, insulin resistance, physical activity were adjusted. <italic toggle="yes">CVD</italic> Cardiovascular disease, <italic toggle="yes">HR</italic> Hazard ratio, <italic toggle="yes">NHR</italic> Neutrophil-to-high-density lipoprotein cholesterol ratio</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec12"><title>Stratified and sensitivity analyses</title><p id="Par27">Stratified analyses revealed that the association between NHR and diabetes risk was more pronounced in female, White participants aged &#8805;&#8201;50 years or former smokers (all <italic toggle="yes">P</italic> for interaction &lt; 0.05;&#160;Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>). When stratified by education level, PIR categories, drinking status, statin use, and physical activity levels, the association remained consistent (all <italic toggle="yes">P</italic> for interactions &gt;&#8201;0.05; Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>). Sensitivity analyses consistently supported these findings: the association remained significant when excluding participants lacking fasting blood glucose measurements (Supplemental Table <xref rid="MOESM1" ref-type="media">2</xref>), when restricting to complete cases (Supplemental Table <xref rid="MOESM1" ref-type="media">3</xref>), and when applying multiple imputation for missing data (Supplemental Table <xref rid="MOESM1" ref-type="media">4</xref>). Similarly, the relationship between NHR and the risk of all-cause or cardiovascular mortality in individuals with diabetes was robust when deaths within the first two years of follow-up were excluded (Supplemental Table <xref rid="MOESM1" ref-type="media">5</xref>).<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><p>Subgroup analysis of the association between baseline neutrophil-to-high-density lipoprotein-cholesterol ratio and diabetes. Weighted logistic regression was performed after adjustment for sex, age, race, marital status, education level, body mass index categories, PIR categories, smoking status, drinking status, anti-diabetic drug use, statin use, insulin resistance, physical activity, hypertension, stroke, and heart failure, except for the stratification variable itself</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO3" position="float" orientation="portrait" xlink:href="12902_2025_1978_Fig3_HTML.jpg"/></fig></p></sec></sec><sec id="Sec13"><title>Discussion</title><p id="Par28">In this prospective cohort of U.S. population, we demonstrate that elevated NHR is related to an increased risk of diabetes, and with the risk of diabetes-related all-cause and CVD mortality. A series of stratifications and sensitivity analyses confirmed the robustness of our findings. These findings suggested a potential role for monitoring NHR levels in the management of diabetes and its adverse outcomes.</p><p id="Par29">In recent years, complex hematological predictors have gained prominence in clinical practice. Markers such as the MHR [<xref ref-type="bibr" rid="CR27">27</xref>], systemic immune-inflammatory index [<xref ref-type="bibr" rid="CR28">28</xref>], and triglyceride glucose index [<xref ref-type="bibr" rid="CR29">29</xref>] have been employed to assess diabetes risk and its complications, highlighting the critical role of inflammation and lipid metabolism in diabetes development. NHR, a novel composite indicator derived from peripheral blood neutrophil count and HDL-C levels [<xref ref-type="bibr" rid="CR30">30</xref>], provides a unique advantage by simultaneously capturing the interplay between lipid metabolism and inflammatory pathways, as well as the interaction between HDL-C and neutrophils [<xref ref-type="bibr" rid="CR31">31</xref>]. We, for the first time, demonstrated that elevated NHR with risk of diabetes after adjustment for potential confounders, suggesting its novel role in the pathogenesis of diabetes. Inflammation (increased neutrophils) and dyslipidemia (low HDL-C) are two important pathological processes that initiate and promote atherosclerotic CVD [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. Previous studies revealed the predictive role of NHR in early renal dysfunction and albuminuria and risk of diabetic kidney disease among diabetic patients [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. A recent post hoc analysis of Kailuan cohort study further showed that pre-diabetic participants with high NHR levels tended to have greater adverse cardiovascular outcomes [<xref ref-type="bibr" rid="CR36">36</xref>]. Based on previous results, we further demonstrate that NHR may be an effective marker for future death from all causes and CVD in the diabetic population. With further validation in large-scale cohorts, integrating NHR levels into routine diabetes screening parameters&#8212;including fasting glucose and HbA1c measurements&#8212;could potentially enhance risk stratification for both suspected and confirmed diabetic patients in clinical practice.</p><p id="Par30">Another notable finding of our study was the significant interaction between the association of NHR and diabetes risk with age, sex, ethnicity and smoking status. We hypothesize that in individuals with stronger risk factors, such as Mexican American and smoking, the role of NHR may be overshadowed, as these conditions are already strongly predisposed to diabetes development [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Interestingly, NHR demonstrated a stronger predictive ability for all-cause and cardiovascular mortality in women with diabetes compared to men. These results suggest that monitoring and controlling NHR could offer additional benefits in reducing diabetes risk and its adverse outcomes, even in individuals without traditional risk factors. Although missing covariates or early deaths could potentially confound the findings, our sensitivity analyses confirmed the robustness of the association by including only participants with complete data or excluding deaths that occurred within the first two years of follow-up.</p><p id="Par31">Several potential biological mechanisms may explain how NHR affect diabetes risk and its adverse cardiovascular outcomes, even if the precise processes underlying this correlation are still unclear. Higher glycemia and dysfunctional HDL-C in diabetes are closely associated with the severity of inflammatory responses and the risk of all-cause and cardiovascular mortality [<xref ref-type="bibr" rid="CR8">8</xref>&#8211;<xref ref-type="bibr" rid="CR11">11</xref>]. First, the NHR can not only present both inflammatory state and lipid metabolism, but also indicate the interaction between neutrophils and HDL-C. The neutrophil burden is elevated in diabetic patients with advanced atherosclerotic plaques, conferring a higher risk of cardiovascular mortality. Low HDL-C has also been shown to significantly accelerate atherosclerosis in diabetic patients [<xref ref-type="bibr" rid="CR39">39</xref>]. Second, chronic exposure to hyperglycemia, in conjunction with dyslipidemia and persistent subclinical inflammation, drives the pathophysiological progression of macrovascular complications in diabetes [<xref ref-type="bibr" rid="CR40">40</xref>]. Abnormal glycemic levels promote oxidative stress and excessive free radical accumulation in endothelial cells. This triggers multiple inflammatory pathways, leading to vasoconstriction and enhanced platelet adhesion [<xref ref-type="bibr" rid="CR41">41</xref>]. Furthermore, as the predominant leukocyte subset, neutrophils serve as more sensitive biomarkers of CVD risk compared to monocytes and lymphocytes [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Thus, these mechanisms may support NHR's predictive utility for diabetes risk and its related mortality.</p><sec id="Sec14"><title>Strengths and limitations</title><p id="Par32">This study has several notable strengths: first, NHANES includes large and representative sample size of U.S. population. Second, comprehensive adjustments for confounding factors and extensive sensitivity analyses were performed, enhancing the reliability of the results. Third, NHR, derived from routine blood tests and biochemical analyses, is both cost-effective and easily accessible, making it a promising tool for diabetes prediction and management. Its potential warrants further in-depth investigation.</p><p id="Par33">However, several limitations need to be highlighted. First, identifying diabetes through questionnaires may introduce recall bias, or recording errors. Some asymptomatic diabetic population who did not have blood tests may be missed. Second, although we carefully adjusted for known risk factors, residual confounding may persist due to unmeasured variables including diabetes duration and severity, medication adherence, dietary patterns, and genetic predisposition, which could potentially influence the observed associations. Third, this post hoc analysis was based on U.S. population, and its applicability to other ethnic populations cannot be directly inferred. Finally, the current analysis is observational, and causality cannot be inferred from the associations observed.</p></sec></sec><sec id="Sec15"><title>Conclusions</title><p id="Par34">In conclusion, we demonstrated the NHR was positively associated with the risk of diabetes and all-cause and CVD mortality in diabetic patients. Further studies are warranted to validate its clinical application in diabetes management.</p></sec><sec id="Sec118" sec-type="supplementary-material"><title>Supplementary Information</title><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="12902_2025_1978_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary Material 1.</p></caption></media></supplementary-material></p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>BMI</term><def><p id="Par6">Body mass index</p></def></def-item><def-item><term>CVD</term><def><p id="Par7">Cardiovascular disease</p></def></def-item><def-item><term>HbA1c</term><def><p id="Par8">Glycated hemoglobin</p></def></def-item><def-item><term>HDL-C</term><def><p id="Par9">High-density lipoprotein cholesterol</p></def></def-item><def-item><term>MHR</term><def><p id="Par10">Monocyte to high-density lipoprotein cholesterol ratio</p></def></def-item><def-item><term>NHANES</term><def><p id="Par11">National Health and Nutrition Survey</p></def></def-item><def-item><term>NHR</term><def><p id="Par12">Neutrophil to high-density lipoprotein cholesterol ratio</p></def></def-item><def-item><term>PIR</term><def><p id="Par13">Poverty-to-income ratio</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors express their gratitude to the NHANES database for their uploading valuable datasets.</p></ack><notes notes-type="author-contribution"><title>Authors' contributions
</title><p>Y.T.: conceptualization, methodology, data curation, software, writing &#8211; original draft. Y.L.: data curation, visualization, software. S.G.: writing&#8211;methodology. C.D.: conceptualization, funding acquisition, methodology, writing &#8211;review &amp; editing, supervision.</p><sec id="FPar1"><title>Institutional review board statement</title><p id="Par35">There was no requirement for institutional review board permission since the NHANES database was open to the public.</p></sec></notes><notes notes-type="funding-information"><title>Funding</title><p>This research received no external funding.</p></notes><notes notes-type="data-availability"><title>Data availability
</title><p>In this study, publicly accessible datasets were examined. These data can be found here: (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx">https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx</ext-link>, Accessed on 1 September 2023).</p></notes><notes><title>Declarations</title><notes id="FPar2"><title>Ethics approval and consent to participate</title><p id="Par36">This study was reviewed and approved by the NCHS Ethics Review Board in accordance with the Declaration of Helsinki. The patients/participants provided written informed consent to participate in this study.</p></notes><notes id="FPar3"><title>Consent for publication</title><p id="Par37">Not applicable.</p></notes><notes id="FPar4" notes-type="COI-statement"><title>Competing interests
</title><p id="Par38">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D, Williams R; IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.diabres.2019.107843</pub-id><pub-id pub-id-type="pmid">31518657</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zimmet</surname><given-names>P</given-names></name><name name-style="western"><surname>Alberti</surname><given-names>KG</given-names></name><name name-style="western"><surname>Magliano</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>PH</given-names></name></person-group><article-title>Diabetes mellitus statistics on prevalence and mortality: facts and fallacies</article-title><source>Nat Rev Endocrinol</source><year>2016</year><volume>12</volume><issue>10</issue><fpage>616</fpage><lpage>622</lpage><pub-id pub-id-type="doi">10.1038/nrendo.2016.105</pub-id><pub-id pub-id-type="pmid">27388988</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Zimmet P, Alberti KG, Magliano DJ, Bennett PH. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol. 2016;12(10):616&#8211;22.<pub-id pub-id-type="pmid">27388988</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrendo.2016.105</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ley</surname><given-names>SH</given-names></name><name name-style="western"><surname>Hu</surname><given-names>FB</given-names></name></person-group><article-title>Global aetiology and epidemiology of type 2 diabetes mellitus and its complications</article-title><source>Nat Rev Endocrinol</source><year>2018</year><volume>14</volume><issue>2</issue><fpage>88</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1038/nrendo.2017.151</pub-id><pub-id pub-id-type="pmid">29219149</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88&#8211;98.<pub-id pub-id-type="pmid">29219149</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrendo.2017.151</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Halim</surname><given-names>M</given-names></name><name name-style="western"><surname>Halim</surname><given-names>A</given-names></name></person-group><article-title>The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes)</article-title><source>Diabetes Metab Syndr</source><year>2019</year><volume>13</volume><issue>2</issue><fpage>1165</fpage><lpage>1172</lpage><pub-id pub-id-type="doi">10.1016/j.dsx.2019.01.040</pub-id><pub-id pub-id-type="pmid">31336460</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Halim M, Halim A. The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes). Diabetes Metab Syndr. 2019;13(2):1165&#8211;72.<pub-id pub-id-type="pmid">31336460</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.dsx.2019.01.040</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nie</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Kan</surname><given-names>H</given-names></name></person-group><article-title>Association between systemic immune-inflammation index and diabetes: a population-based study from the NHANES</article-title><source>Front Endocrinol (Lausanne)</source><year>2023</year><volume>14</volume><fpage>1245199</fpage><pub-id pub-id-type="doi">10.3389/fendo.2023.1245199</pub-id><pub-id pub-id-type="pmid">38027115</pub-id><pub-id pub-id-type="pmcid">PMC10644783</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Nie Y, Zhou H, Wang J, Kan H. Association between systemic immune-inflammation index and diabetes: a population-based study from the NHANES. Front Endocrinol (Lausanne). 2023;14:1245199.<pub-id pub-id-type="pmid">38027115</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fendo.2023.1245199</pub-id><pub-id pub-id-type="pmcid">PMC10644783</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xepapadaki</surname><given-names>E</given-names></name><name name-style="western"><surname>Nikdima</surname><given-names>I</given-names></name><name name-style="western"><surname>Sagiadinou</surname><given-names>EC</given-names></name><name name-style="western"><surname>Zvintzou</surname><given-names>E</given-names></name><name name-style="western"><surname>Kypreos</surname><given-names>KE</given-names></name></person-group><article-title>HDL and type 2 diabetes: the chicken or the egg?</article-title><source>Diabetologia</source><year>2021</year><volume>64</volume><issue>9</issue><fpage>1917</fpage><lpage>1926</lpage><pub-id pub-id-type="doi">10.1007/s00125-021-05509-0</pub-id><pub-id pub-id-type="pmid">34255113</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Xepapadaki E, Nikdima I, Sagiadinou EC, Zvintzou E, Kypreos KE. HDL and type 2 diabetes: the chicken or the egg? Diabetologia. 2021;64(9):1917&#8211;26.<pub-id pub-id-type="pmid">34255113</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00125-021-05509-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>N</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cui</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name></person-group><article-title>Association between neutrophil-to-high-density lipoprotein cholesterol ratio and non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease: evidence from NHANES 2017&#8211;2020</article-title><source>Front Med (Lausanne)</source><year>2025</year><volume>11</volume><fpage>1491858</fpage><pub-id pub-id-type="doi">10.3389/fmed.2024.1491858</pub-id><pub-id pub-id-type="pmid">39882525</pub-id><pub-id pub-id-type="pmcid">PMC11774988</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Zhu N, Li Y, Lin Y, Cui X, Li X. Association between neutrophil-to-high-density lipoprotein cholesterol ratio and non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease: evidence from NHANES 2017&#8211;2020. Front Med (Lausanne). 2025;11:1491858.<pub-id pub-id-type="pmid">39882525</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmed.2024.1491858</pub-id><pub-id pub-id-type="pmcid">PMC11774988</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>G</given-names></name><name name-style="western"><surname>Gan</surname><given-names>M</given-names></name><name name-style="western"><surname>Xu</surname><given-names>S</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><name name-style="western"><surname>Wu</surname><given-names>L</given-names></name></person-group><article-title>The neutrophil-lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diabetes: evidence from the NHANES 2003&#8211;2016</article-title><source>Cardiovasc Diabetol</source><year>2023</year><volume>22</volume><issue>1</issue><fpage>267</fpage><pub-id pub-id-type="doi">10.1186/s12933-023-01998-y</pub-id><pub-id pub-id-type="pmid">37775767</pub-id><pub-id pub-id-type="pmcid">PMC10541705</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Dong G, Gan M, Xu S, Xie Y, Zhou M, Wu L. The neutrophil-lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diabetes: evidence from the NHANES 2003&#8211;2016. Cardiovasc Diabetol. 2023;22(1):267.<pub-id pub-id-type="pmid">37775767</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12933-023-01998-y</pub-id><pub-id pub-id-type="pmcid">PMC10541705</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adane</surname><given-names>T</given-names></name><name name-style="western"><surname>Melku</surname><given-names>M</given-names></name><name name-style="western"><surname>Worku</surname><given-names>YB</given-names></name><name name-style="western"><surname>Fasil</surname><given-names>A</given-names></name><name name-style="western"><surname>Aynalem</surname><given-names>M</given-names></name><name name-style="western"><surname>Kelem</surname><given-names>A</given-names></name><name name-style="western"><surname>Getawa</surname><given-names>S</given-names></name></person-group><article-title>The Association between neutrophil-to-lymphocyte ratio and glycemic control in type 2 diabetes mellitus: A systematic review and meta-analysis</article-title><source>J Diabetes Res</source><year>2023</year><volume>2023</volume><fpage>3117396</fpage><pub-id pub-id-type="doi">10.1155/2023/3117396</pub-id><pub-id pub-id-type="pmid">37305430</pub-id><pub-id pub-id-type="pmcid">PMC10257553</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Adane T, Melku M, Worku YB, Fasil A, Aynalem M, Kelem A, Getawa S. The Association between neutrophil-to-lymphocyte ratio and glycemic control in type 2 diabetes mellitus: A systematic review and meta-analysis. J Diabetes Res. 2023;2023:3117396.<pub-id pub-id-type="pmid">37305430</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2023/3117396</pub-id><pub-id pub-id-type="pmcid">PMC10257553</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barter</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Rye</surname><given-names>KA</given-names></name><name name-style="western"><surname>Tardif</surname><given-names>JC</given-names></name><name name-style="western"><surname>Waters</surname><given-names>DD</given-names></name><name name-style="western"><surname>Boekholdt</surname><given-names>SM</given-names></name><name name-style="western"><surname>Breazna</surname><given-names>A</given-names></name><name name-style="western"><surname>Kastelein</surname><given-names>JJ</given-names></name></person-group><article-title>Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial</article-title><source>Circulation</source><year>2011</year><volume>124</volume><issue>5</issue><fpage>555</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.018259</pub-id><pub-id pub-id-type="pmid">21804130</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Barter PJ, Rye KA, Tardif JC, Waters DD, Boekholdt SM, Breazna A, Kastelein JJ. Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial. Circulation. 2011;124(5):555&#8211;62.<pub-id pub-id-type="pmid">21804130</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCULATIONAHA.111.018259</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kunutsor</surname><given-names>SK</given-names></name><name name-style="western"><surname>Kieneker</surname><given-names>LM</given-names></name><name name-style="western"><surname>Bakker</surname><given-names>SJL</given-names></name><name name-style="western"><surname>James</surname><given-names>RW</given-names></name><name name-style="western"><surname>Dullaart</surname><given-names>RPF</given-names></name></person-group><article-title>Incident type 2 diabetes is associated with HDL, but not with its anti-oxidant constituent - paraoxonase-1: The prospective cohort PREVEND study</article-title><source>Metabolism</source><year>2017</year><volume>73</volume><fpage>43</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.metabol.2017.05.004</pub-id><pub-id pub-id-type="pmid">28732570</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Kunutsor SK, Kieneker LM, Bakker SJL, James RW, Dullaart RPF. Incident type 2 diabetes is associated with HDL, but not with its anti-oxidant constituent - paraoxonase-1: The prospective cohort PREVEND study. Metabolism. 2017;73:43&#8211;51.<pub-id pub-id-type="pmid">28732570</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.metabol.2017.05.004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cogny</surname><given-names>A</given-names></name><name name-style="western"><surname>Atger</surname><given-names>V</given-names></name><name name-style="western"><surname>Paul</surname><given-names>JL</given-names></name><name name-style="western"><surname>Soni</surname><given-names>T</given-names></name><name name-style="western"><surname>Moatti</surname><given-names>N</given-names></name></person-group><article-title>High-density lipoprotein 3 physicochemical modifications induced by interaction with human polymorphonuclear leucocytes affect their ability to remove cholesterol from cells</article-title><source>Biochem J</source><year>1996</year><volume>314</volume><fpage>285</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1042/bj3140285</pub-id><pub-id pub-id-type="pmid">8660296</pub-id><pub-id pub-id-type="pmcid">PMC1217038</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Cogny A, Atger V, Paul JL, Soni T, Moatti N. High-density lipoprotein 3 physicochemical modifications induced by interaction with human polymorphonuclear leucocytes affect their ability to remove cholesterol from cells. Biochem J. 1996;314:285&#8211;92.<pub-id pub-id-type="pmid">8660296</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1042/bj3140285</pub-id><pub-id pub-id-type="pmcid">PMC1217038</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Curcic</surname><given-names>S</given-names></name><name name-style="western"><surname>Holzer</surname><given-names>M</given-names></name><name name-style="western"><surname>Frei</surname><given-names>R</given-names></name><name name-style="western"><surname>Pasterk</surname><given-names>L</given-names></name><name name-style="western"><surname>Schicho</surname><given-names>R</given-names></name><name name-style="western"><surname>Heinemann</surname><given-names>A</given-names></name><name name-style="western"><surname>Marsche</surname><given-names>G</given-names></name></person-group><article-title>Neutrophil effector responses are suppressed by secretory phospholipase A2 modified HDL</article-title><source>Biochim Biophys Acta</source><year>2015</year><volume>1851</volume><issue>2</issue><fpage>184</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2014.11.010</pub-id><pub-id pub-id-type="pmid">25463476</pub-id><pub-id pub-id-type="pmcid">PMC4789498</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Curcic S, Holzer M, Frei R, Pasterk L, Schicho R, Heinemann A, Marsche G. Neutrophil effector responses are suppressed by secretory phospholipase A2 modified HDL. Biochim Biophys Acta. 2015;1851(2):184&#8211;93.<pub-id pub-id-type="pmid">25463476</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbalip.2014.11.010</pub-id><pub-id pub-id-type="pmcid">PMC4789498</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korkmaz</surname><given-names>&#350;A</given-names></name><name name-style="western"><surname>K&#305;zg&#305;n</surname><given-names>S</given-names></name></person-group><article-title>Neutrophil/high-density lipoprotein cholesterol (HDL), monocyte/HDL and platelet/HDL ratios are increased in acute mania as markers of inflammation, even after controlling for confounding factors</article-title><source>Curr Med Res Opin</source><year>2023</year><volume>39</volume><issue>10</issue><fpage>1383</fpage><lpage>1390</lpage><pub-id pub-id-type="doi">10.1080/03007995.2023.2260302</pub-id><pub-id pub-id-type="pmid">37725087</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Korkmaz &#350;A, K&#305;zg&#305;n S. Neutrophil/high-density lipoprotein cholesterol (HDL), monocyte/HDL and platelet/HDL ratios are increased in acute mania as markers of inflammation, even after controlling for confounding factors. Curr Med Res Opin. 2023;39(10):1383&#8211;90.<pub-id pub-id-type="pmid">37725087</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/03007995.2023.2260302</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>M</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J</given-names></name><name name-style="western"><surname>Zou</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Su</surname><given-names>Z</given-names></name><name name-style="western"><surname>Sun</surname><given-names>W</given-names></name><name name-style="western"><surname>Kong</surname><given-names>X</given-names></name></person-group><article-title>Prognostic role of neutrophil to high-density lipoprotein cholesterol ratio for all-cause and cardiovascular mortality in the general population</article-title><source>Front Cardiovasc Med</source><year>2022</year><volume>9</volume><fpage>807339</fpage><pub-id pub-id-type="doi">10.3389/fcvm.2022.807339</pub-id><pub-id pub-id-type="pmid">35211525</pub-id><pub-id pub-id-type="pmcid">PMC8861276</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Jiang M, Sun J, Zou H, Li M, Su Z, Sun W, Kong X. Prognostic role of neutrophil to high-density lipoprotein cholesterol ratio for all-cause and cardiovascular mortality in the general population. Front Cardiovasc Med. 2022;9: 807339.<pub-id pub-id-type="pmid">35211525</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcvm.2022.807339</pub-id><pub-id pub-id-type="pmcid">PMC8861276</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>JB</given-names></name><name name-style="western"><surname>Chen</surname><given-names>YS</given-names></name><name name-style="western"><surname>Ji</surname><given-names>HY</given-names></name><name name-style="western"><surname>Xie</surname><given-names>WM</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>J</given-names></name><name name-style="western"><surname>Ran</surname><given-names>LS</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>CT</given-names></name><name name-style="western"><surname>Quan</surname><given-names>XQ</given-names></name></person-group><article-title>Neutrophil to high-density lipoprotein ratio has a superior prognostic value in elderly patients with acute myocardial infarction: a comparison study</article-title><source>Lipids Health Dis</source><year>2020</year><volume>19</volume><issue>1</issue><fpage>59</fpage><pub-id pub-id-type="doi">10.1186/s12944-020-01238-2</pub-id><pub-id pub-id-type="pmid">32247314</pub-id><pub-id pub-id-type="pmcid">PMC7126405</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Huang JB, Chen YS, Ji HY, Xie WM, Jiang J, Ran LS, Zhang CT, Quan XQ. Neutrophil to high-density lipoprotein ratio has a superior prognostic value in elderly patients with acute myocardial infarction: a comparison study. Lipids Health Dis. 2020;19(1):59.<pub-id pub-id-type="pmid">32247314</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12944-020-01238-2</pub-id><pub-id pub-id-type="pmcid">PMC7126405</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Fan</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wu</surname><given-names>S</given-names></name><name name-style="western"><surname>Wan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lei</surname><given-names>Y</given-names></name></person-group><article-title>Compared with the monocyte to high-density lipoprotein ratio (MHR) and the neutrophil to lymphocyte ratio (NLR), the neutrophil to high-density lipoprotein ratio (NHR) is more valuable for assessing the inflammatory process in Parkinson&#8217;s disease</article-title><source>Lipids Health Dis</source><year>2021</year><volume>20</volume><issue>1</issue><fpage>35</fpage><pub-id pub-id-type="doi">10.1186/s12944-021-01462-4</pub-id><pub-id pub-id-type="pmid">33874966</pub-id><pub-id pub-id-type="pmcid">PMC8054377</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Liu Z, Fan Q, Wu S, Wan Y, Lei Y. Compared with the monocyte to high-density lipoprotein ratio (MHR) and the neutrophil to lymphocyte ratio (NLR), the neutrophil to high-density lipoprotein ratio (NHR) is more valuable for assessing the inflammatory process in Parkinson&#8217;s disease. Lipids Health Dis. 2021;20(1):35.<pub-id pub-id-type="pmid">33874966</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12944-021-01462-4</pub-id><pub-id pub-id-type="pmcid">PMC8054377</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="other">Zhang Y, Ding Y, Jiang W. Neutrophil and monocyte ratios to high-density lipoprotein cholesterol as biomarkers in non-dipping hypertension. Clin Exp Hypertens. 2023;45(1):2210785:59.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/10641963.2023.2210785</pub-id><pub-id pub-id-type="pmid">37165667</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>G</given-names></name><name name-style="western"><surname>Yang</surname><given-names>N</given-names></name><name name-style="western"><surname>Ren</surname><given-names>J</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H</given-names></name><name name-style="western"><surname>Hu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Neutrophil counts to high-density lipoprotein cholesterol ratio: a potential predictor of prognosis in acute ischemic stroke patients after intravenous thrombolysis</article-title><source>Neurotox Res</source><year>2020</year><volume>38</volume><issue>4</issue><fpage>1001</fpage><lpage>1009</lpage><pub-id pub-id-type="doi">10.1007/s12640-020-00274-1</pub-id><pub-id pub-id-type="pmid">32894456</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Chen G, Yang N, Ren J, He Y, Huang H, Hu X, et al. Neutrophil counts to high-density lipoprotein cholesterol ratio: a potential predictor of prognosis in acute ischemic stroke patients after intravenous thrombolysis. Neurotox Res. 2020;38(4):1001&#8211;9.<pub-id pub-id-type="pmid">32894456</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12640-020-00274-1</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Pho</surname><given-names>N</given-names></name><name name-style="western"><surname>McDuffie</surname><given-names>M</given-names></name><name name-style="western"><surname>Easton-Marks</surname><given-names>J</given-names></name><name name-style="western"><surname>Kothari</surname><given-names>C</given-names></name><name name-style="western"><surname>Kohane</surname><given-names>IS</given-names></name><name name-style="western"><surname>Avillach</surname><given-names>P</given-names></name></person-group><article-title>A database of human exposomes and phenomes from the US National Health and Nutrition Examination Survey</article-title><source>Sci Data</source><year>2016</year><volume>3</volume><fpage>160096</fpage><pub-id pub-id-type="doi">10.1038/sdata.2016.96</pub-id><pub-id pub-id-type="pmid">27779619</pub-id><pub-id pub-id-type="pmcid">PMC5079122</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Patel CJ, Pho N, McDuffie M, Easton-Marks J, Kothari C, Kohane IS, Avillach P. A database of human exposomes and phenomes from the US National Health and Nutrition Examination Survey. Sci Data. 2016;3: 160096.<pub-id pub-id-type="pmid">27779619</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sdata.2016.96</pub-id><pub-id pub-id-type="pmcid">PMC5079122</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="other">American Diabetes Association. 2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes&#8212;2021. Diabetes Care. 2021;44 Supplement_1:S15&#8211;33.<pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/dc21-S002</pub-id><pub-id pub-id-type="pmid">33298413</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Guo</surname><given-names>J</given-names></name><name name-style="western"><surname>Pan</surname><given-names>A</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>G</given-names></name></person-group><article-title>Association of serum 25-hydroxyvitamin D concentrations with all-cause and cause-specific mortality among individuals with diabetes</article-title><source>Diabetes Care</source><year>2021</year><volume>44</volume><issue>2</issue><fpage>350</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.2337/dc20-1485</pub-id><pub-id pub-id-type="pmid">33168652</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Wan Z, Guo J, Pan A, Chen C, Liu L, Liu G. Association of serum 25-hydroxyvitamin D concentrations with all-cause and cause-specific mortality among individuals with diabetes. Diabetes Care. 2021;44(2):350&#8211;7.<pub-id pub-id-type="pmid">33168652</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/dc20-1485</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bao</surname><given-names>W</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B</given-names></name><name name-style="western"><surname>Simonsen</surname><given-names>DW</given-names></name><name name-style="western"><surname>Lehmler</surname><given-names>HJ</given-names></name></person-group><article-title>Association between exposure to pyrethroid insecticides and risk of all-cause and cause-specific mortality in the general US adult population</article-title><source>JAMA Intern Med</source><year>2020</year><volume>180</volume><issue>3</issue><fpage>367</fpage><pub-id pub-id-type="doi">10.1001/jamainternmed.2019.6019</pub-id><pub-id pub-id-type="pmid">31886824</pub-id><pub-id pub-id-type="pmcid">PMC6990752</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Bao W, Liu B, Simonsen DW, Lehmler HJ. Association between exposure to pyrethroid insecticides and risk of all-cause and cause-specific mortality in the general US adult population. JAMA Intern Med. 2020;180(3):367.<pub-id pub-id-type="pmid">31886824</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamainternmed.2019.6019</pub-id><pub-id pub-id-type="pmcid">PMC6990752</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wallace</surname><given-names>TM</given-names></name><name name-style="western"><surname>Levy</surname><given-names>JC</given-names></name><name name-style="western"><surname>Matthews</surname><given-names>DR</given-names></name></person-group><article-title>Use and abuse of HOMA modeling</article-title><source>Diabetes Care</source><year>2004</year><volume>27</volume><fpage>1487</fpage><lpage>1495</lpage><pub-id pub-id-type="doi">10.2337/diacare.27.6.1487</pub-id><pub-id pub-id-type="pmid">15161807</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487&#8211;95.<pub-id pub-id-type="pmid">15161807</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/diacare.27.6.1487</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yin</surname><given-names>B</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Xia</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>S</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name></person-group><article-title>Non-linear association of atherogenic index of plasma with insulin resistance and type 2 diabetes: a cross-sectional study</article-title><source>Cardiovasc Diabetol</source><year>2023</year><volume>22</volume><fpage>157</fpage><pub-id pub-id-type="doi">10.1186/s12933-023-01886-5</pub-id><pub-id pub-id-type="pmid">37386500</pub-id><pub-id pub-id-type="pmcid">PMC10311747</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Yin B, Wu Z, Xia Y, Xiao S, Chen L, Li Y. Non-linear association of atherogenic index of plasma with insulin resistance and type 2 diabetes: a cross-sectional study. Cardiovasc Diabetol. 2023;22:157.<pub-id pub-id-type="pmid">37386500</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12933-023-01886-5</pub-id><pub-id pub-id-type="pmcid">PMC10311747</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">Johnson CL, Paulose-Ram R, Ogden CL, Carroll MD, Kruszon-Moran D, Dohrmann SM, Curtin LR. National health and nutrition examination survey: analytic guidelines, 1999&#8211;2010. Vital Health Stat 2. 2013;(161):1&#8211;24.<pub-id pub-id-type="pmid">25090154</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Lin</surname><given-names>X</given-names></name><name name-style="western"><surname>Bo</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>F</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><name name-style="western"><surname>Miao</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>D</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Fan</surname><given-names>Q</given-names></name></person-group><article-title>Monocyte to high-density lipoprotein cholesterol ratio predicts poor outcomes in ischaemic heart failure patients combined with diabetes: a retrospective study</article-title><source>Eur J Med Res</source><year>2023</year><volume>28</volume><issue>1</issue><fpage>493</fpage><pub-id pub-id-type="doi">10.1186/s40001-023-01451-6</pub-id><pub-id pub-id-type="pmid">37941037</pub-id><pub-id pub-id-type="pmcid">PMC10631131</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Li Q, Lin X, Bo X, Li F, Chen S, Miao X, Zhao D, Liu J, Fan Q. Monocyte to high-density lipoprotein cholesterol ratio predicts poor outcomes in ischaemic heart failure patients combined with diabetes: a retrospective study. Eur J Med Res. 2023;28(1):493.<pub-id pub-id-type="pmid">37941037</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40001-023-01451-6</pub-id><pub-id pub-id-type="pmcid">PMC10631131</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Huang</surname><given-names>R</given-names></name><name name-style="western"><surname>Mai</surname><given-names>Z</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yu</surname><given-names>H</given-names></name><name name-style="western"><surname>Kong</surname><given-names>D</given-names></name><name name-style="western"><surname>Ding</surname><given-names>Y</given-names></name></person-group><article-title>Association between systemic immune-inflammatory index and diabetes mellitus: mediation analysis involving obesity indicators in the NHANES</article-title><source>Front Public Health</source><year>2024</year><volume>11</volume><fpage>1331159</fpage><pub-id pub-id-type="doi">10.3389/fpubh.2023.1331159</pub-id><pub-id pub-id-type="pmid">38269383</pub-id><pub-id pub-id-type="pmcid">PMC10806151</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Chen Y, Huang R, Mai Z, Chen H, Zhang J, Zhao L, Yang Z, Yu H, Kong D, Ding Y. Association between systemic immune-inflammatory index and diabetes mellitus: mediation analysis involving obesity indicators in the NHANES. Front Public Health. 2024;11:1331159.<pub-id pub-id-type="pmid">38269383</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fpubh.2023.1331159</pub-id><pub-id pub-id-type="pmcid">PMC10806151</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>S</given-names></name><name name-style="western"><surname>Jiao</surname><given-names>X</given-names></name><name name-style="western"><surname>Shen</surname><given-names>Y</given-names></name></person-group><article-title>The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001&#8211;2018</article-title><source>Cardiovasc Diabetol</source><year>2023</year><volume>22</volume><fpage>279</fpage><pub-id pub-id-type="doi">10.1186/s12933-023-02030-z</pub-id><pub-id pub-id-type="pmid">37848879</pub-id><pub-id pub-id-type="pmcid">PMC10583314</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Zhang Q, Xiao S, Jiao X, Shen Y. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001&#8211;2018. Cardiovasc Diabetol. 2023;22:279.<pub-id pub-id-type="pmid">37848879</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12933-023-02030-z</pub-id><pub-id pub-id-type="pmcid">PMC10583314</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leonardi</surname><given-names>S</given-names></name><name name-style="western"><surname>Gragnano</surname><given-names>F</given-names></name><name name-style="western"><surname>Carrara</surname><given-names>G</given-names></name><name name-style="western"><surname>Gargiulo</surname><given-names>G</given-names></name><name name-style="western"><surname>Frigoli</surname><given-names>E</given-names></name><name name-style="western"><surname>Vranckx</surname><given-names>P</given-names></name><name name-style="western"><surname>Di Maio</surname><given-names>D</given-names></name><name name-style="western"><surname>Spedicato</surname><given-names>V</given-names></name><name name-style="western"><surname>Monda</surname><given-names>E</given-names></name><name name-style="western"><surname>Fimiani</surname><given-names>L</given-names></name><name name-style="western"><surname>Fioretti</surname><given-names>V</given-names></name><name name-style="western"><surname>Esposito</surname><given-names>F</given-names></name><name name-style="western"><surname>Avvedimento</surname><given-names>M</given-names></name><name name-style="western"><surname>Magliulo</surname><given-names>F</given-names></name><name name-style="western"><surname>Leone</surname><given-names>A</given-names></name><name name-style="western"><surname>Chianese</surname><given-names>S</given-names></name><name name-style="western"><surname>Franzese</surname><given-names>M</given-names></name><name name-style="western"><surname>Scalise</surname><given-names>M</given-names></name><name name-style="western"><surname>Schiavo</surname><given-names>A</given-names></name><name name-style="western"><surname>Mazzone</surname><given-names>P</given-names></name><name name-style="western"><surname>Esposito</surname><given-names>G</given-names></name><name name-style="western"><surname>And&#242;</surname><given-names>G</given-names></name><name name-style="western"><surname>Calabr&#242;</surname><given-names>P</given-names></name><name name-style="western"><surname>Windecker</surname><given-names>S</given-names></name><name name-style="western"><surname>Valgimigli</surname><given-names>M</given-names></name></person-group><article-title>prognostic implications of declining Hemoglobin content in patients hospitalized with acute coronary syndromes</article-title><source>J Am Coll Cardiol</source><year>2021</year><volume>77</volume><issue>4</issue><fpage>375</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2020.11.046</pub-id><pub-id pub-id-type="pmid">33509394</pub-id><pub-id pub-id-type="pmcid">PMC8091415</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Leonardi S, Gragnano F, Carrara G, Gargiulo G, Frigoli E, Vranckx P, Di Maio D, Spedicato V, Monda E, Fimiani L, Fioretti V, Esposito F, Avvedimento M, Magliulo F, Leone A, Chianese S, Franzese M, Scalise M, Schiavo A, Mazzone P, Esposito G, And&#242; G, Calabr&#242; P, Windecker S, Valgimigli M. prognostic implications of declining Hemoglobin content in patients hospitalized with acute coronary syndromes. J Am Coll Cardiol. 2021;77(4):375&#8211;88.<pub-id pub-id-type="pmid">33509394</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0735-1097(21)01734-4</pub-id><pub-id pub-id-type="pmcid">PMC8091415</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qing</surname><given-names>G</given-names></name><name name-style="western"><surname>Bao</surname><given-names>C</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wei</surname><given-names>B</given-names></name></person-group><article-title>Association between neutrophil to high-density lipoprotein cholesterol ratio (NHR) and depression symptoms among the United States adults: a cross-sectional study</article-title><source>Lipids Health Dis</source><year>2024</year><volume>23</volume><issue>1</issue><fpage>215</fpage><pub-id pub-id-type="doi">10.1186/s12944-024-02204-y</pub-id><pub-id pub-id-type="pmid">39003458</pub-id><pub-id pub-id-type="pmcid">PMC11245866</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Qing G, Bao C, Yang Y, Wei B. Association between neutrophil to high-density lipoprotein cholesterol ratio (NHR) and depression symptoms among the United States adults: a cross-sectional study. Lipids Health Dis. 2024;23(1):215.<pub-id pub-id-type="pmid">39003458</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12944-024-02204-y</pub-id><pub-id pub-id-type="pmcid">PMC11245866</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kain</surname><given-names>V</given-names></name><name name-style="western"><surname>Halade</surname><given-names>GV</given-names></name></person-group><article-title>Role of neutrophils in ischemic heart failure</article-title><source>Pharmacol Ther</source><year>2020</year><volume>205</volume><fpage>107424</fpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2019.107424</pub-id><pub-id pub-id-type="pmid">31629005</pub-id><pub-id pub-id-type="pmcid">PMC6981275</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Kain V, Halade GV. Role of neutrophils in ischemic heart failure. Pharmacol Ther. 2020;205: 107424.<pub-id pub-id-type="pmid">31629005</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pharmthera.2019.107424</pub-id><pub-id pub-id-type="pmcid">PMC6981275</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montecucco</surname><given-names>F</given-names></name><name name-style="western"><surname>Liberale</surname><given-names>L</given-names></name><name name-style="western"><surname>Bonaventura</surname><given-names>A</given-names></name><name name-style="western"><surname>Vecchi&#232;</surname><given-names>A</given-names></name><name name-style="western"><surname>Dallegri</surname><given-names>F</given-names></name><name name-style="western"><surname>Carbone</surname><given-names>F</given-names></name></person-group><article-title>The role of inflammation in cardiovascular outcome</article-title><source>Curr Atheroscler Rep</source><year>2017</year><volume>19</volume><issue>3</issue><fpage>11</fpage><pub-id pub-id-type="doi">10.1007/s11883-017-0646-1</pub-id><pub-id pub-id-type="pmid">28194569</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Montecucco F, Liberale L, Bonaventura A, Vecchi&#232; A, Dallegri F, Carbone F. The role of inflammation in cardiovascular outcome. Curr Atheroscler Rep. 2017;19(3):11.<pub-id pub-id-type="pmid">28194569</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11883-017-0646-1</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kawamoto</surname><given-names>R</given-names></name><name name-style="western"><surname>Ninomiya</surname><given-names>D</given-names></name><name name-style="western"><surname>Kikuchi</surname><given-names>A</given-names></name><name name-style="western"><surname>Akase</surname><given-names>T</given-names></name><name name-style="western"><surname>Kasai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kusunoki</surname><given-names>T</given-names></name><name name-style="western"><surname>Ohtsuka</surname><given-names>N</given-names></name><name name-style="western"><surname>Kumagi</surname><given-names>T</given-names></name></person-group><article-title>Association of neutrophil-to-lymphocyte ratio with early renal dysfunction and albuminuria among diabetic patients</article-title><source>Int Urol Nephrol</source><year>2019</year><volume>51</volume><issue>3</issue><fpage>483</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.1007/s11255-018-02065-2</pub-id><pub-id pub-id-type="pmid">30607775</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Kawamoto R, Ninomiya D, Kikuchi A, Akase T, Kasai Y, Kusunoki T, Ohtsuka N, Kumagi T. Association of neutrophil-to-lymphocyte ratio with early renal dysfunction and albuminuria among diabetic patients. Int Urol Nephrol. 2019;51(3):483&#8211;90.<pub-id pub-id-type="pmid">30607775</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11255-018-02065-2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name><name name-style="western"><surname>Xu</surname><given-names>H</given-names></name></person-group><article-title>Association between neutrophil-to-lymphocyte ratio and diabetic kidney disease in type 2 diabetes mellitus patients: a cross-sectional study</article-title><source>Front Endocrinol (Lausanne)</source><year>2024</year><volume>14</volume><fpage>1285509</fpage><pub-id pub-id-type="doi">10.3389/fendo.2023.1285509</pub-id><pub-id pub-id-type="pmid">38239986</pub-id><pub-id pub-id-type="pmcid">PMC10795842</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Li X, Wang L, Liu M, Zhou H, Xu H. Association between neutrophil-to-lymphocyte ratio and diabetic kidney disease in type 2 diabetes mellitus patients: a cross-sectional study. Front Endocrinol (Lausanne). 2024;14:1285509.<pub-id pub-id-type="pmid">38239986</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fendo.2023.1285509</pub-id><pub-id pub-id-type="pmcid">PMC10795842</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>SL</given-names></name><name name-style="western"><surname>Feng</surname><given-names>BY</given-names></name><name name-style="western"><surname>Song</surname><given-names>QR</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>YM</given-names></name><name name-style="western"><surname>Wu</surname><given-names>SL</given-names></name><name name-style="western"><surname>Cai</surname><given-names>J</given-names></name></person-group><article-title>Neutrophil to high-density lipoprotein cholesterol ratio predicts adverse cardiovascular outcomes in subjects with pre-diabetes: a large cohort study from China</article-title><source>Lipids Health Dis</source><year>2022</year><volume>21</volume><issue>1</issue><fpage>86</fpage><pub-id pub-id-type="doi">10.1186/s12944-022-01695-x</pub-id><pub-id pub-id-type="pmid">36057713</pub-id><pub-id pub-id-type="pmcid">PMC9441053</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Liu SL, Feng BY, Song QR, Zhang YM, Wu SL, Cai J. Neutrophil to high-density lipoprotein cholesterol ratio predicts adverse cardiovascular outcomes in subjects with pre-diabetes: a large cohort study from China. Lipids Health Dis. 2022;21(1):86.<pub-id pub-id-type="pmid">36057713</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12944-022-01695-x</pub-id><pub-id pub-id-type="pmcid">PMC9441053</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Kanaya</surname><given-names>AM</given-names></name><name name-style="western"><surname>Araneta</surname><given-names>MRG</given-names></name><name name-style="western"><surname>Saydah</surname><given-names>SH</given-names></name><name name-style="western"><surname>Kahn</surname><given-names>HS</given-names></name><name name-style="western"><surname>Gregg</surname><given-names>EW</given-names></name><name name-style="western"><surname>Fujimoto</surname><given-names>WY</given-names></name><name name-style="western"><surname>Imperatore</surname><given-names>G</given-names></name></person-group><article-title>Prevalence of diabetes by race and ethnicity in the United States, 2011&#8211;2016</article-title><source>JAMA</source><year>2019</year><volume>322</volume><issue>24</issue><fpage>2389</fpage><lpage>2398</lpage><pub-id pub-id-type="doi">10.1001/jama.2019.19365</pub-id><pub-id pub-id-type="pmid">31860047</pub-id><pub-id pub-id-type="pmcid">PMC6990660</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Cheng YJ, Kanaya AM, Araneta MRG, Saydah SH, Kahn HS, Gregg EW, Fujimoto WY, Imperatore G. Prevalence of diabetes by race and ethnicity in the United States, 2011&#8211;2016. JAMA. 2019;322(24):2389&#8211;98.<pub-id pub-id-type="pmid">31860047</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2019.19365</pub-id><pub-id pub-id-type="pmcid">PMC6990660</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Durlach</surname><given-names>V</given-names></name><name name-style="western"><surname>Verg&#232;s</surname><given-names>B</given-names></name><name name-style="western"><surname>Al-Salameh</surname><given-names>A</given-names></name><name name-style="western"><surname>Bahougne</surname><given-names>T</given-names></name><name name-style="western"><surname>Benzerouk</surname><given-names>F</given-names></name><name name-style="western"><surname>Berlin</surname><given-names>I</given-names></name><name name-style="western"><surname>Clair</surname><given-names>C</given-names></name><name name-style="western"><surname>Mansourati</surname><given-names>J</given-names></name><name name-style="western"><surname>Rouland</surname><given-names>A</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>D</given-names></name><name name-style="western"><surname>Thuillier</surname><given-names>P</given-names></name><name name-style="western"><surname>Tramunt</surname><given-names>B</given-names></name><name name-style="western"><surname>Le Faou</surname><given-names>AL</given-names></name></person-group><article-title>Smoking and diabetes interplay: A comprehensive review and joint statement</article-title><source>Diabetes Metab</source><year>2022</year><volume>48</volume><issue>6</issue><fpage>101370</fpage><pub-id pub-id-type="doi">10.1016/j.diabet.2022.101370</pub-id><pub-id pub-id-type="pmid">35779852</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Durlach V, Verg&#232;s B, Al-Salameh A, Bahougne T, Benzerouk F, Berlin I, Clair C, Mansourati J, Rouland A, Thomas D, Thuillier P, Tramunt B, Le Faou AL. Smoking and diabetes interplay: A comprehensive review and joint statement. Diabetes Metab. 2022;48(6): 101370.<pub-id pub-id-type="pmid">35779852</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.diabet.2022.101370</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ren</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Deng</surname><given-names>G</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ma</surname><given-names>B</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name><name name-style="western"><surname>Ali Sheikh</surname><given-names>MS</given-names></name><name name-style="western"><surname>Xia</surname><given-names>K</given-names></name></person-group><article-title>Neutrophil to high-density lipoprotein cholesterol ratio as the risk mark in patients with type 2 diabetes combined with acute coronary syndrome: a cross-sectional study</article-title><source>Sci Rep</source><year>2023</year><volume>13</volume><issue>1</issue><fpage>7836</fpage><pub-id pub-id-type="doi">10.1038/s41598-023-35050-6</pub-id><pub-id pub-id-type="pmid">37188740</pub-id><pub-id pub-id-type="pmcid">PMC10185574</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Ren H, Zhu B, Zhao Z, Li Y, Deng G, Wang Z, Ma B, Feng Y, Zhang Z, Zhao X, Ali Sheikh MS, Xia K. Neutrophil to high-density lipoprotein cholesterol ratio as the risk mark in patients with type 2 diabetes combined with acute coronary syndrome: a cross-sectional study. Sci Rep. 2023;13(1):7836.<pub-id pub-id-type="pmid">37188740</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-023-35050-6</pub-id><pub-id pub-id-type="pmcid">PMC10185574</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paneni</surname><given-names>F</given-names></name><name name-style="western"><surname>Beckman</surname><given-names>JA</given-names></name><name name-style="western"><surname>Creager</surname><given-names>MA</given-names></name><name name-style="western"><surname>Cosentino</surname><given-names>F</given-names></name></person-group><article-title>Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I</article-title><source>Eur Heart J</source><year>2013</year><volume>34</volume><issue>31</issue><fpage>2436</fpage><lpage>2443</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/eht149</pub-id><pub-id pub-id-type="pmid">23641007</pub-id><pub-id pub-id-type="pmcid">PMC3743069</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013;34(31):2436&#8211;43.<pub-id pub-id-type="pmid">23641007</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/eurheartj/eht149</pub-id><pub-id pub-id-type="pmcid">PMC3743069</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cosentino</surname><given-names>F</given-names></name><name name-style="western"><surname>Camici</surname><given-names>GG</given-names></name><name name-style="western"><surname>Akhmedov</surname><given-names>A</given-names></name><name name-style="western"><surname>Vanhoutte</surname><given-names>PM</given-names></name><name name-style="western"><surname>Tanner</surname><given-names>FC</given-names></name><name name-style="western"><surname>L&#252;scher</surname><given-names>TF</given-names></name></person-group><article-title>Oxidized low-density lipoprotein activates p66Shc via lectin-like oxidized low-density lipoprotein receptor-1, protein kinase C-beta, and c-Jun N-terminal kinase kinase in human endothelial cells</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2011</year><volume>31</volume><issue>9</issue><fpage>2090</fpage><lpage>2097</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.111.229260</pub-id><pub-id pub-id-type="pmid">21817106</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Shi Y, Cosentino F, Camici GG, Akhmedov A, Vanhoutte PM, Tanner FC, L&#252;scher TF. Oxidized low-density lipoprotein activates p66Shc via lectin-like oxidized low-density lipoprotein receptor-1, protein kinase C-beta, and c-Jun N-terminal kinase kinase in human endothelial cells. Arterioscler Thromb Vasc Biol. 2011;31(9):2090&#8211;7.<pub-id pub-id-type="pmid">21817106</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/ATVBAHA.111.229260</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>